Tumor-based pharmacokinetics has greater significance for anticancer drugs than does blood-based pharmacokinetics [3] (multiple letters)

Clinical Pharmacology and Therapeutics

Volumn 76, Issue 5, 2004, Pages 508-

  Wolf, Walter ^a   Presant, Cary A ^b,c   Joel, Simon ^d   Seymour, Matthew ^e  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b California Cancer Medical Center   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^e United Kingdom   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORINE 18; FLUOROURACIL; OXALIPLATIN;

ANTINEOPLASTIC ACTIVITY; BLOOD SAMPLING; BOLUS INJECTION; CORRELATION ANALYSIS; DRUG ANTAGONISM; DRUG CLEARANCE; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG RESPONSE; HUMAN; INFUSION; ISOTOPE LABELING; LETTER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TOXICITY;

EID: 7944235867     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2004.08.012     Document Type: Letter

References (0)